洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2100046077】USING MACHINE LEARNING TO PREDICT KIDNEY INJURY AFTER LOWER LIMB ANGIOPLASTY

基本信息
登记号

ChiCTR2100046077

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-05-04

临床申请受理号

/

靶点

/

适应症

Contrast Associated Acute Kidney Injury

试验通俗题目

USING MACHINE LEARNING TO PREDICT KIDNEY INJURY AFTER LOWER LIMB ANGIOPLASTY

试验专业题目

MACHINE LEARNING PREDICTS CONTRAST INDUCED ACUTE KIDNEY INJURY IN ELECTIVE LOWER LIMB PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY: A RETROSPECTIVE COHORT

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

169608

联系人通讯地址
临床试验信息
试验目的

Examine risk factors for contrast associated acute kidney injury after elective lower limb percutaneous transluminal angioplasty. Develop machine learning models for risk prediction.

试验分类
试验类型

连续入组

试验分期

回顾性研究

随机化

Not applicable as this is a retrospective cohort.

盲法

Not applicable as this is a retrospective cohort.

试验项目经费来源

No funding

试验范围

/

目标入组人数

610

实际入组人数

/

第一例入组时间

2020-07-01

试验终止时间

2021-07-01

是否属于一致性

/

入选标准

- All cases of lower limb PTA as a single procedure identified via surgical codes; - Performed at Singapore General Hospital; - Recruitment period from 2014 to 2020.;

排除标准

- Patients <21 years old; - Patients with a preoperative estimated Glomerular Filtration Rate (eGFR) of <15mL/min/1.73 m2 as defined by the Modification of Diet in Renal Disease (MDRD); - Patients with no valid preoperative or postoperative SCr.;

研究者信息
研究负责人姓名
试验机构

Singapore General Hospital

研究负责人电话
研究负责人邮箱
研究负责人邮编

169608

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品